Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M BARR

Showing results (771-780 of 848) with videos related to

Pageof 85
Sort By:
Future Oncology (London, England)|December 10, 2025
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphomaNathalie A Johnson, Pier Luigi Zinzani, Eva Domingo-Domenech, et al.
Pediatric Obesity|January 17, 2019
Maternal body mass index, excess gestational weight gain, and diabetes are positively associated with neonatal adiposity in the Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) studyDanielle K Longmore, Elizabeth L M Barr, I-Lynn Lee, et al.
The Clinical Neuropsychologist|February 15, 2023
Using serial position effects to investigate memory dysfunction in homeless and precariously housed personsKristina M Gicas, Katie Benitah, Allen E Thornton, et al.
Blood|July 24, 2019
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphomaDeborah M Stephens, Hongli Li, Heiko Schöder, et al.
Canadian Journal of Kidney Health and Disease|August 20, 2025
Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort StudyElizabeth L M Barr, Federica Barzi, Phillip Mills Kulkalgal, et al.
Blood|July 16, 2016
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapyVindi Jurinovic, Robert Kridel, Annette M Staiger, et al.
Plos One|November 14, 2013
Personalized risk assessment of drug-related harm is associated with health outcomesAndrea A Jones, Fidel Vila-Rodriguez, William J Panenka, et al.
Diabetologia|September 10, 2020
Associations of gestational diabetes and type 2 diabetes during pregnancy with breastfeeding at hospital discharge and up to 6 months: the PANDORA studyDanielle K Longmore, Elizabeth L M Barr, Alyce N Wilson, et al.
Blood|February 23, 2022
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohortConstantine S Tam, John N Allan, Tanya Siddiqi, et al.
Blood Advances|October 23, 2023
Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemiaBrian T Hill, Shuo Ma, Clive S Zent, et al.
Pageof 85

Showing results (771-780 of 848) with videos related to

Sort By:
Pageof 85
Future Oncology (London, England)|December 10, 2025
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphomaNathalie A Johnson, Pier Luigi Zinzani, Eva Domingo-Domenech, et al.
Pediatric Obesity|January 17, 2019
Maternal body mass index, excess gestational weight gain, and diabetes are positively associated with neonatal adiposity in the Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) studyDanielle K Longmore, Elizabeth L M Barr, I-Lynn Lee, et al.
The Clinical Neuropsychologist|February 15, 2023
Using serial position effects to investigate memory dysfunction in homeless and precariously housed personsKristina M Gicas, Katie Benitah, Allen E Thornton, et al.
Blood|July 24, 2019
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphomaDeborah M Stephens, Hongli Li, Heiko Schöder, et al.
Canadian Journal of Kidney Health and Disease|August 20, 2025
Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort StudyElizabeth L M Barr, Federica Barzi, Phillip Mills Kulkalgal, et al.
Blood|July 16, 2016
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapyVindi Jurinovic, Robert Kridel, Annette M Staiger, et al.
Plos One|November 14, 2013
Personalized risk assessment of drug-related harm is associated with health outcomesAndrea A Jones, Fidel Vila-Rodriguez, William J Panenka, et al.
Diabetologia|September 10, 2020
Associations of gestational diabetes and type 2 diabetes during pregnancy with breastfeeding at hospital discharge and up to 6 months: the PANDORA studyDanielle K Longmore, Elizabeth L M Barr, Alyce N Wilson, et al.
Blood|February 23, 2022
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohortConstantine S Tam, John N Allan, Tanya Siddiqi, et al.
Blood Advances|October 23, 2023
Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemiaBrian T Hill, Shuo Ma, Clive S Zent, et al.
Pageof 85